In this issue of the Journal Thrombosis and Haemostasis, Campioni et al report correction dominant‐negative von Willebrand disease (VWD) in vivo for first time. particular, they demonstrate that targeted inhibition a mutant VWF allele can significantly improve bleeding phenotype Type 2A VWD murine model. Collectively, these data move us another step closer to developing personalized approaches ...